[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Multi-Cancer Detection Blood Test Supply, Demand and Key Producers, 2023-2029

September 2023 | 107 pages | ID: G8FF362ED161EN
GlobalInfoResearch

US$ 4,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Multi-Cancer Detection Blood Test market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

The Multi-Cancer Detection Blood Test, also known as a liquid biopsy or pan-cancer test, is a type of medical test that aims to detect multiple types of cancer in the body using a blood sample. Unlike traditional cancer screenings that focus on specific cancer types, this test is designed to provide a more comprehensive assessment by detecting various cancer-related biomarkers or genetic alterations present in the bloodstream.

The Multi-Cancer Detection Blood Test holds promise for early cancer detection, as it can potentially identify cancers at an earlier stage when treatment options are more effective and outcomes are better. It may also aid in monitoring cancer patients during treatment and post-treatment to detect recurrence or treatment response.

This report studies the global Multi-Cancer Detection Blood Test production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Multi-Cancer Detection Blood Test, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Multi-Cancer Detection Blood Test that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Multi-Cancer Detection Blood Test total production and demand, 2018-2029, (K Units)

Global Multi-Cancer Detection Blood Test total production value, 2018-2029, (USD Million)

Global Multi-Cancer Detection Blood Test production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global Multi-Cancer Detection Blood Test consumption by region & country, CAGR, 2018-2029 & (K Units)

U.S. VS China: Multi-Cancer Detection Blood Test domestic production, consumption, key domestic manufacturers and share

Global Multi-Cancer Detection Blood Test production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)

Global Multi-Cancer Detection Blood Test production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global Multi-Cancer Detection Blood Test production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).

This reports profiles key players in the global Multi-Cancer Detection Blood Test market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Galleri, Amadix, Burning Rock, Exact Sciences, Freenome, AnchorDx, Guardant Health, Foundation Medicine and GENECAST, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Multi-Cancer Detection Blood Test market.

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Multi-Cancer Detection Blood Test Market, By Region:
  • United States
  • China
  • Europe
  • Japan
  • South Korea
  • ASEAN
  • India
  • Rest of World
Global Multi-Cancer Detection Blood Test Market, Segmentation by Type
  • ctDNA-Based Tests
  • Protein Biomarker-Based Tests
  • Methylation-Based Tests
  • Others
Global Multi-Cancer Detection Blood Test Market, Segmentation by Application
  • Hospitals
  • Diagnostic Laboratories
  • Others
Companies Profiled:
  • Galleri
  • Amadix
  • Burning Rock
  • Exact Sciences
  • Freenome
  • AnchorDx
  • Guardant Health
  • Foundation Medicine
  • GENECAST
  • Coyne Medical
  • Laboratory for Advanced Medicine
  • Singlera Genomics
Key Questions Answered

1. How big is the global Multi-Cancer Detection Blood Test market?

2. What is the demand of the global Multi-Cancer Detection Blood Test market?

3. What is the year over year growth of the global Multi-Cancer Detection Blood Test market?

4. What is the production and production value of the global Multi-Cancer Detection Blood Test market?

5. Who are the key producers in the global Multi-Cancer Detection Blood Test market?

6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY

1.1 Multi-Cancer Detection Blood Test Introduction
1.2 World Multi-Cancer Detection Blood Test Supply & Forecast
  1.2.1 World Multi-Cancer Detection Blood Test Production Value (2018 & 2022 & 2029)
  1.2.2 World Multi-Cancer Detection Blood Test Production (2018-2029)
  1.2.3 World Multi-Cancer Detection Blood Test Pricing Trends (2018-2029)
1.3 World Multi-Cancer Detection Blood Test Production by Region (Based on Production Site)
  1.3.1 World Multi-Cancer Detection Blood Test Production Value by Region (2018-2029)
  1.3.2 World Multi-Cancer Detection Blood Test Production by Region (2018-2029)
  1.3.3 World Multi-Cancer Detection Blood Test Average Price by Region (2018-2029)
  1.3.4 North America Multi-Cancer Detection Blood Test Production (2018-2029)
  1.3.5 Europe Multi-Cancer Detection Blood Test Production (2018-2029)
  1.3.6 China Multi-Cancer Detection Blood Test Production (2018-2029)
  1.3.7 Japan Multi-Cancer Detection Blood Test Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
  1.4.1 Multi-Cancer Detection Blood Test Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 Multi-Cancer Detection Blood Test Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
  1.5.1 Influence of COVID-19
  1.5.2 Influence of Russia-Ukraine War

2 DEMAND SUMMARY

2.1 World Multi-Cancer Detection Blood Test Demand (2018-2029)
2.2 World Multi-Cancer Detection Blood Test Consumption by Region
  2.2.1 World Multi-Cancer Detection Blood Test Consumption by Region (2018-2023)
  2.2.2 World Multi-Cancer Detection Blood Test Consumption Forecast by Region (2024-2029)
2.3 United States Multi-Cancer Detection Blood Test Consumption (2018-2029)
2.4 China Multi-Cancer Detection Blood Test Consumption (2018-2029)
2.5 Europe Multi-Cancer Detection Blood Test Consumption (2018-2029)
2.6 Japan Multi-Cancer Detection Blood Test Consumption (2018-2029)
2.7 South Korea Multi-Cancer Detection Blood Test Consumption (2018-2029)
2.8 ASEAN Multi-Cancer Detection Blood Test Consumption (2018-2029)
2.9 India Multi-Cancer Detection Blood Test Consumption (2018-2029)

3 WORLD MULTI-CANCER DETECTION BLOOD TEST MANUFACTURERS COMPETITIVE ANALYSIS

3.1 World Multi-Cancer Detection Blood Test Production Value by Manufacturer (2018-2023)
3.2 World Multi-Cancer Detection Blood Test Production by Manufacturer (2018-2023)
3.3 World Multi-Cancer Detection Blood Test Average Price by Manufacturer (2018-2023)
3.4 Multi-Cancer Detection Blood Test Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
  3.5.1 Global Multi-Cancer Detection Blood Test Industry Rank of Major Manufacturers
  3.5.2 Global Concentration Ratios (CR4) for Multi-Cancer Detection Blood Test in 2022
  3.5.3 Global Concentration Ratios (CR8) for Multi-Cancer Detection Blood Test in 2022
3.6 Multi-Cancer Detection Blood Test Market: Overall Company Footprint Analysis
  3.6.1 Multi-Cancer Detection Blood Test Market: Region Footprint
  3.6.2 Multi-Cancer Detection Blood Test Market: Company Product Type Footprint
  3.6.3 Multi-Cancer Detection Blood Test Market: Company Product Application Footprint
3.7 Competitive Environment
  3.7.1 Historical Structure of the Industry
  3.7.2 Barriers of Market Entry
  3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 UNITED STATES VS CHINA VS REST OF THE WORLD

4.1 United States VS China: Multi-Cancer Detection Blood Test Production Value Comparison
  4.1.1 United States VS China: Multi-Cancer Detection Blood Test Production Value Comparison (2018 & 2022 & 2029)
  4.1.2 United States VS China: Multi-Cancer Detection Blood Test Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Multi-Cancer Detection Blood Test Production Comparison
  4.2.1 United States VS China: Multi-Cancer Detection Blood Test Production Comparison (2018 & 2022 & 2029)
  4.2.2 United States VS China: Multi-Cancer Detection Blood Test Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Multi-Cancer Detection Blood Test Consumption Comparison
  4.3.1 United States VS China: Multi-Cancer Detection Blood Test Consumption Comparison (2018 & 2022 & 2029)
  4.3.2 United States VS China: Multi-Cancer Detection Blood Test Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Multi-Cancer Detection Blood Test Manufacturers and Market Share, 2018-2023
  4.4.1 United States Based Multi-Cancer Detection Blood Test Manufacturers, Headquarters and Production Site (States, Country)
  4.4.2 United States Based Manufacturers Multi-Cancer Detection Blood Test Production Value (2018-2023)
  4.4.3 United States Based Manufacturers Multi-Cancer Detection Blood Test Production (2018-2023)
4.5 China Based Multi-Cancer Detection Blood Test Manufacturers and Market Share
  4.5.1 China Based Multi-Cancer Detection Blood Test Manufacturers, Headquarters and Production Site (Province, Country)
  4.5.2 China Based Manufacturers Multi-Cancer Detection Blood Test Production Value (2018-2023)
  4.5.3 China Based Manufacturers Multi-Cancer Detection Blood Test Production (2018-2023)
4.6 Rest of World Based Multi-Cancer Detection Blood Test Manufacturers and Market Share, 2018-2023
  4.6.1 Rest of World Based Multi-Cancer Detection Blood Test Manufacturers, Headquarters and Production Site (State, Country)
  4.6.2 Rest of World Based Manufacturers Multi-Cancer Detection Blood Test Production Value (2018-2023)
  4.6.3 Rest of World Based Manufacturers Multi-Cancer Detection Blood Test Production (2018-2023)

5 MARKET ANALYSIS BY TYPE

5.1 World Multi-Cancer Detection Blood Test Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
  5.2.1 ctDNA-Based Tests
  5.2.2 Protein Biomarker-Based Tests
  5.2.3 Methylation-Based Tests
  5.2.4 Others
5.3 Market Segment by Type
  5.3.1 World Multi-Cancer Detection Blood Test Production by Type (2018-2029)
  5.3.2 World Multi-Cancer Detection Blood Test Production Value by Type (2018-2029)
  5.3.3 World Multi-Cancer Detection Blood Test Average Price by Type (2018-2029)

6 MARKET ANALYSIS BY APPLICATION

6.1 World Multi-Cancer Detection Blood Test Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
  6.2.1 Hospitals
  6.2.2 Diagnostic Laboratories
  6.2.3 Others
6.3 Market Segment by Application
  6.3.1 World Multi-Cancer Detection Blood Test Production by Application (2018-2029)
  6.3.2 World Multi-Cancer Detection Blood Test Production Value by Application (2018-2029)
  6.3.3 World Multi-Cancer Detection Blood Test Average Price by Application (2018-2029)

7 COMPANY PROFILES

7.1 Galleri
  7.1.1 Galleri Details
  7.1.2 Galleri Major Business
  7.1.3 Galleri Multi-Cancer Detection Blood Test Product and Services
  7.1.4 Galleri Multi-Cancer Detection Blood Test Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.1.5 Galleri Recent Developments/Updates
  7.1.6 Galleri Competitive Strengths & Weaknesses
7.2 Amadix
  7.2.1 Amadix Details
  7.2.2 Amadix Major Business
  7.2.3 Amadix Multi-Cancer Detection Blood Test Product and Services
  7.2.4 Amadix Multi-Cancer Detection Blood Test Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.2.5 Amadix Recent Developments/Updates
  7.2.6 Amadix Competitive Strengths & Weaknesses
7.3 Burning Rock
  7.3.1 Burning Rock Details
  7.3.2 Burning Rock Major Business
  7.3.3 Burning Rock Multi-Cancer Detection Blood Test Product and Services
  7.3.4 Burning Rock Multi-Cancer Detection Blood Test Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.3.5 Burning Rock Recent Developments/Updates
  7.3.6 Burning Rock Competitive Strengths & Weaknesses
7.4 Exact Sciences
  7.4.1 Exact Sciences Details
  7.4.2 Exact Sciences Major Business
  7.4.3 Exact Sciences Multi-Cancer Detection Blood Test Product and Services
  7.4.4 Exact Sciences Multi-Cancer Detection Blood Test Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.4.5 Exact Sciences Recent Developments/Updates
  7.4.6 Exact Sciences Competitive Strengths & Weaknesses
7.5 Freenome
  7.5.1 Freenome Details
  7.5.2 Freenome Major Business
  7.5.3 Freenome Multi-Cancer Detection Blood Test Product and Services
  7.5.4 Freenome Multi-Cancer Detection Blood Test Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.5.5 Freenome Recent Developments/Updates
  7.5.6 Freenome Competitive Strengths & Weaknesses
7.6 AnchorDx
  7.6.1 AnchorDx Details
  7.6.2 AnchorDx Major Business
  7.6.3 AnchorDx Multi-Cancer Detection Blood Test Product and Services
  7.6.4 AnchorDx Multi-Cancer Detection Blood Test Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.6.5 AnchorDx Recent Developments/Updates
  7.6.6 AnchorDx Competitive Strengths & Weaknesses
7.7 Guardant Health
  7.7.1 Guardant Health Details
  7.7.2 Guardant Health Major Business
  7.7.3 Guardant Health Multi-Cancer Detection Blood Test Product and Services
  7.7.4 Guardant Health Multi-Cancer Detection Blood Test Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.7.5 Guardant Health Recent Developments/Updates
  7.7.6 Guardant Health Competitive Strengths & Weaknesses
7.8 Foundation Medicine
  7.8.1 Foundation Medicine Details
  7.8.2 Foundation Medicine Major Business
  7.8.3 Foundation Medicine Multi-Cancer Detection Blood Test Product and Services
  7.8.4 Foundation Medicine Multi-Cancer Detection Blood Test Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.8.5 Foundation Medicine Recent Developments/Updates
  7.8.6 Foundation Medicine Competitive Strengths & Weaknesses
7.9 GENECAST
  7.9.1 GENECAST Details
  7.9.2 GENECAST Major Business
  7.9.3 GENECAST Multi-Cancer Detection Blood Test Product and Services
  7.9.4 GENECAST Multi-Cancer Detection Blood Test Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.9.5 GENECAST Recent Developments/Updates
  7.9.6 GENECAST Competitive Strengths & Weaknesses
7.10 Coyne Medical
  7.10.1 Coyne Medical Details
  7.10.2 Coyne Medical Major Business
  7.10.3 Coyne Medical Multi-Cancer Detection Blood Test Product and Services
  7.10.4 Coyne Medical Multi-Cancer Detection Blood Test Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.10.5 Coyne Medical Recent Developments/Updates
  7.10.6 Coyne Medical Competitive Strengths & Weaknesses
7.11 Laboratory for Advanced Medicine
  7.11.1 Laboratory for Advanced Medicine Details
  7.11.2 Laboratory for Advanced Medicine Major Business
  7.11.3 Laboratory for Advanced Medicine Multi-Cancer Detection Blood Test Product and Services
  7.11.4 Laboratory for Advanced Medicine Multi-Cancer Detection Blood Test Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.11.5 Laboratory for Advanced Medicine Recent Developments/Updates
  7.11.6 Laboratory for Advanced Medicine Competitive Strengths & Weaknesses
7.12 Singlera Genomics
  7.12.1 Singlera Genomics Details
  7.12.2 Singlera Genomics Major Business
  7.12.3 Singlera Genomics Multi-Cancer Detection Blood Test Product and Services
  7.12.4 Singlera Genomics Multi-Cancer Detection Blood Test Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.12.5 Singlera Genomics Recent Developments/Updates
  7.12.6 Singlera Genomics Competitive Strengths & Weaknesses

8 INDUSTRY CHAIN ANALYSIS

8.1 Multi-Cancer Detection Blood Test Industry Chain
8.2 Multi-Cancer Detection Blood Test Upstream Analysis
  8.2.1 Multi-Cancer Detection Blood Test Core Raw Materials
  8.2.2 Main Manufacturers of Multi-Cancer Detection Blood Test Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Multi-Cancer Detection Blood Test Production Mode
8.6 Multi-Cancer Detection Blood Test Procurement Model
8.7 Multi-Cancer Detection Blood Test Industry Sales Model and Sales Channels
  8.7.1 Multi-Cancer Detection Blood Test Sales Model
  8.7.2 Multi-Cancer Detection Blood Test Typical Customers

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

LIST OF TABLES

Table 1. World Multi-Cancer Detection Blood Test Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Multi-Cancer Detection Blood Test Production Value by Region (2018-2023) & (USD Million)
Table 3. World Multi-Cancer Detection Blood Test Production Value by Region (2024-2029) & (USD Million)
Table 4. World Multi-Cancer Detection Blood Test Production Value Market Share by Region (2018-2023)
Table 5. World Multi-Cancer Detection Blood Test Production Value Market Share by Region (2024-2029)
Table 6. World Multi-Cancer Detection Blood Test Production by Region (2018-2023) & (K Units)
Table 7. World Multi-Cancer Detection Blood Test Production by Region (2024-2029) & (K Units)
Table 8. World Multi-Cancer Detection Blood Test Production Market Share by Region (2018-2023)
Table 9. World Multi-Cancer Detection Blood Test Production Market Share by Region (2024-2029)
Table 10. World Multi-Cancer Detection Blood Test Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Multi-Cancer Detection Blood Test Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Multi-Cancer Detection Blood Test Major Market Trends
Table 13. World Multi-Cancer Detection Blood Test Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Multi-Cancer Detection Blood Test Consumption by Region (2018-2023) & (K Units)
Table 15. World Multi-Cancer Detection Blood Test Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Multi-Cancer Detection Blood Test Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Multi-Cancer Detection Blood Test Producers in 2022
Table 18. World Multi-Cancer Detection Blood Test Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Multi-Cancer Detection Blood Test Producers in 2022
Table 20. World Multi-Cancer Detection Blood Test Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Multi-Cancer Detection Blood Test Company Evaluation Quadrant
Table 22. World Multi-Cancer Detection Blood Test Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Multi-Cancer Detection Blood Test Production Site of Key Manufacturer
Table 24. Multi-Cancer Detection Blood Test Market: Company Product Type Footprint
Table 25. Multi-Cancer Detection Blood Test Market: Company Product Application Footprint
Table 26. Multi-Cancer Detection Blood Test Competitive Factors
Table 27. Multi-Cancer Detection Blood Test New Entrant and Capacity Expansion Plans
Table 28. Multi-Cancer Detection Blood Test Mergers & Acquisitions Activity
Table 29. United States VS China Multi-Cancer Detection Blood Test Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Multi-Cancer Detection Blood Test Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Multi-Cancer Detection Blood Test Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Multi-Cancer Detection Blood Test Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Multi-Cancer Detection Blood Test Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Multi-Cancer Detection Blood Test Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Multi-Cancer Detection Blood Test Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Multi-Cancer Detection Blood Test Production Market Share (2018-2023)
Table 37. China Based Multi-Cancer Detection Blood Test Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Multi-Cancer Detection Blood Test Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Multi-Cancer Detection Blood Test Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Multi-Cancer Detection Blood Test Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Multi-Cancer Detection Blood Test Production Market Share (2018-2023)
Table 42. Rest of World Based Multi-Cancer Detection Blood Test Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Multi-Cancer Detection Blood Test Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Multi-Cancer Detection Blood Test Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Multi-Cancer Detection Blood Test Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Multi-Cancer Detection Blood Test Production Market Share (2018-2023)
Table 47. World Multi-Cancer Detection Blood Test Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Multi-Cancer Detection Blood Test Production by Type (2018-2023) & (K Units)
Table 49. World Multi-Cancer Detection Blood Test Production by Type (2024-2029) & (K Units)
Table 50. World Multi-Cancer Detection Blood Test Production Value by Type (2018-2023) & (USD Million)
Table 51. World Multi-Cancer Detection Blood Test Production Value by Type (2024-2029) & (USD Million)
Table 52. World Multi-Cancer Detection Blood Test Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Multi-Cancer Detection Blood Test Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Multi-Cancer Detection Blood Test Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Multi-Cancer Detection Blood Test Production by Application (2018-2023) & (K Units)
Table 56. World Multi-Cancer Detection Blood Test Production by Application (2024-2029) & (K Units)
Table 57. World Multi-Cancer Detection Blood Test Production Value by Application (2018-2023) & (USD Million)
Table 58. World Multi-Cancer Detection Blood Test Production Value by Application (2024-2029) & (USD Million)
Table 59. World Multi-Cancer Detection Blood Test Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Multi-Cancer Detection Blood Test Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Galleri Basic Information, Manufacturing Base and Competitors
Table 62. Galleri Major Business
Table 63. Galleri Multi-Cancer Detection Blood Test Product and Services
Table 64. Galleri Multi-Cancer Detection Blood Test Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Galleri Recent Developments/Updates
Table 66. Galleri Competitive Strengths & Weaknesses
Table 67. Amadix Basic Information, Manufacturing Base and Competitors
Table 68. Amadix Major Business
Table 69. Amadix Multi-Cancer Detection Blood Test Product and Services
Table 70. Amadix Multi-Cancer Detection Blood Test Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Amadix Recent Developments/Updates
Table 72. Amadix Competitive Strengths & Weaknesses
Table 73. Burning Rock Basic Information, Manufacturing Base and Competitors
Table 74. Burning Rock Major Business
Table 75. Burning Rock Multi-Cancer Detection Blood Test Product and Services
Table 76. Burning Rock Multi-Cancer Detection Blood Test Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Burning Rock Recent Developments/Updates
Table 78. Burning Rock Competitive Strengths & Weaknesses
Table 79. Exact Sciences Basic Information, Manufacturing Base and Competitors
Table 80. Exact Sciences Major Business
Table 81. Exact Sciences Multi-Cancer Detection Blood Test Product and Services
Table 82. Exact Sciences Multi-Cancer Detection Blood Test Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Exact Sciences Recent Developments/Updates
Table 84. Exact Sciences Competitive Strengths & Weaknesses
Table 85. Freenome Basic Information, Manufacturing Base and Competitors
Table 86. Freenome Major Business
Table 87. Freenome Multi-Cancer Detection Blood Test Product and Services
Table 88. Freenome Multi-Cancer Detection Blood Test Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Freenome Recent Developments/Updates
Table 90. Freenome Competitive Strengths & Weaknesses
Table 91. AnchorDx Basic Information, Manufacturing Base and Competitors
Table 92. AnchorDx Major Business
Table 93. AnchorDx Multi-Cancer Detection Blood Test Product and Services
Table 94. AnchorDx Multi-Cancer Detection Blood Test Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. AnchorDx Recent Developments/Updates
Table 96. AnchorDx Competitive Strengths & Weaknesses
Table 97. Guardant Health Basic Information, Manufacturing Base and Competitors
Table 98. Guardant Health Major Business
Table 99. Guardant Health Multi-Cancer Detection Blood Test Product and Services
Table 100. Guardant Health Multi-Cancer Detection Blood Test Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Guardant Health Recent Developments/Updates
Table 102. Guardant Health Competitive Strengths & Weaknesses
Table 103. Foundation Medicine Basic Information, Manufacturing Base and Competitors
Table 104. Foundation Medicine Major Business
Table 105. Foundation Medicine Multi-Cancer Detection Blood Test Product and Services
Table 106. Foundation Medicine Multi-Cancer Detection Blood Test Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Foundation Medicine Recent Developments/Updates
Table 108. Foundation Medicine Competitive Strengths & Weaknesses
Table 109. GENECAST Basic Information, Manufacturing Base and Competitors
Table 110. GENECAST Major Business
Table 111. GENECAST Multi-Cancer Detection Blood Test Product and Services
Table 112. GENECAST Multi-Cancer Detection Blood Test Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. GENECAST Recent Developments/Updates
Table 114. GENECAST Competitive Strengths & Weaknesses
Table 115. Coyne Medical Basic Information, Manufacturing Base and Competitors
Table 116. Coyne Medical Major Business
Table 117. Coyne Medical Multi-Cancer Detection Blood Test Product and Services
Table 118. Coyne Medical Multi-Cancer Detection Blood Test Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Coyne Medical Recent Developments/Updates
Table 120. Coyne Medical Competitive Strengths & Weaknesses
Table 121. Laboratory for Advanced Medicine Basic Information, Manufacturing Base and Competitors
Table 122. Laboratory for Advanced Medicine Major Business
Table 123. Laboratory for Advanced Medicine Multi-Cancer Detection Blood Test Product and Services
Table 124. Laboratory for Advanced Medicine Multi-Cancer Detection Blood Test Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Laboratory for Advanced Medicine Recent Developments/Updates
Table 126. Singlera Genomics Basic Information, Manufacturing Base and Competitors
Table 127. Singlera Genomics Major Business
Table 128. Singlera Genomics Multi-Cancer Detection Blood Test Product and Services
Table 129. Singlera Genomics Multi-Cancer Detection Blood Test Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 130. Global Key Players of Multi-Cancer Detection Blood Test Upstream (Raw Materials)
Table 131. Multi-Cancer Detection Blood Test Typical Customers
Table 132. Multi-Cancer Detection Blood Test Typical Distributors
List of Figure
Figure 1. Multi-Cancer Detection Blood Test Picture
Figure 2. World Multi-Cancer Detection Blood Test Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Multi-Cancer Detection Blood Test Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Multi-Cancer Detection Blood Test Production (2018-2029) & (K Units)
Figure 5. World Multi-Cancer Detection Blood Test Average Price (2018-2029) & (US$/Unit)
Figure 6. World Multi-Cancer Detection Blood Test Production Value Market Share by Region (2018-2029)
Figure 7. World Multi-Cancer Detection Blood Test Production Market Share by Region (2018-2029)
Figure 8. North America Multi-Cancer Detection Blood Test Production (2018-2029) & (K Units)
Figure 9. Europe Multi-Cancer Detection Blood Test Production (2018-2029) & (K Units)
Figure 10. China Multi-Cancer Detection Blood Test Production (2018-2029) & (K Units)
Figure 11. Japan Multi-Cancer Detection Blood Test Production (2018-2029) & (K Units)
Figure 12. Multi-Cancer Detection Blood Test Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Multi-Cancer Detection Blood Test Consumption (2018-2029) & (K Units)
Figure 15. World Multi-Cancer Detection Blood Test Consumption Market Share by Region (2018-2029)
Figure 16. United States Multi-Cancer Detection Blood Test Consumption (2018-2029) & (K Units)
Figure 17. China Multi-Cancer Detection Blood Test Consumption (2018-2029) & (K Units)
Figure 18. Europe Multi-Cancer Detection Blood Test Consumption (2018-2029) & (K Units)
Figure 19. Japan Multi-Cancer Detection Blood Test Consumption (2018-2029) & (K Units)
Figure 20. South Korea Multi-Cancer Detection Blood Test Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Multi-Cancer Detection Blood Test Consumption (2018-2029) & (K Units)
Figure 22. India Multi-Cancer Detection Blood Test Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Multi-Cancer Detection Blood Test by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Multi-Cancer Detection Blood Test Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Multi-Cancer Detection Blood Test Markets in 2022
Figure 26. United States VS China: Multi-Cancer Detection Blood Test Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Multi-Cancer Detection Blood Test Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Multi-Cancer Detection Blood Test Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Multi-Cancer Detection Blood Test Production Market Share 2022
Figure 30. China Based Manufacturers Multi-Cancer Detection Blood Test Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Multi-Cancer Detection Blood Test Production Market Share 2022
Figure 32. World Multi-Cancer Detection Blood Test Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Multi-Cancer Detection Blood Test Production Value Market Share by Type in 2022
Figure 34. ctDNA-Based Tests
Figure 35. Protein Biomarker-Based Tests
Figure 36. Methylation-Based Tests
Figure 37. Others
Figure 38. World Multi-Cancer Detection Blood Test Production Market Share by Type (2018-2029)
Figure 39. World Multi-Cancer Detection Blood Test Production Value Market Share by Type (2018-2029)
Figure 40. World Multi-Cancer Detection Blood Test Average Price by Type (2018-2029) & (US$/Unit)
Figure 41. World Multi-Cancer Detection Blood Test Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 42. World Multi-Cancer Detection Blood Test Production Value Market Share by Application in 2022
Figure 43. Hospitals
Figure 44. Diagnostic Laboratories
Figure 45. Others
Figure 46. World Multi-Cancer Detection Blood Test Production Market Share by Application (2018-2029)
Figure 47. World Multi-Cancer Detection Blood Test Production Value Market Share by Application (2018-2029)
Figure 48. World Multi-Cancer Detection Blood Test Average Price by Application (2018-2029) & (US$/Unit)
Figure 49. Multi-Cancer Detection Blood Test Industry Chain
Figure 50. Multi-Cancer Detection Blood Test Procurement Model
Figure 51. Multi-Cancer Detection Blood Test Sales Model
Figure 52. Multi-Cancer Detection Blood Test Sales Channels, Direct Sales, and Distribution
Figure 53. Methodology
Figure 54. Research Process and Data Source


More Publications